Education
About Us
Working with TipRanks
Follow Us
Edesa Biotech Inc (EDSA)
NASDAQ:EDSA
Total Valuation
Edesa Biotech has a market cap or net worth of $14.26M. The enterprise value is $359.39K.
Market Cap$14.26M
Enterprise Value$359.39K
Share Statistics
Edesa Biotech has 7,022,678 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,022,678
Owned by Insiders15.32%
Owned by Institutions28.77%
Financial Efficiency
Edesa Biotech’s return on equity (ROE) is -3.11 and return on invested capital (ROIC) is -350.60%.
Return on Equity (ROE)-3.11
Return on Assets (ROA)-1.62
Return on Invested Capital (ROIC)-350.60%
Return on Capital Employed (ROCE)-3.54
Revenue Per Employee0.00
Profits Per Employee-385.63K
Employee Count16
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Edesa Biotech is -2.31. Edesa Biotech’s PEG ratio is -0.12.
PE Ratio-2.31
PS Ratio0.00
PB Ratio0.69
Price to Fair Value7.18
Price to FCF-2.49
Price to Operating Cash Flow-1.88
PEG Ratio-0.12
Income Statement
In the last 12 months, Edesa Biotech had revenue of 0.00 and earned -6.17M in profits. Earnings per share was -1.93.
Revenue0.00
Gross Profit0.00
Operating Income-7.01M
Pretax Income-6.17M
Net Income-6.17M
EBITDA-5.98M
Earnings Per Share (EPS)-1.93
Cash Flow
In the last 12 months, operating cash flow was -5.72M and capital expenditures 0.00, giving a free cash flow of -5.72M billion.
Operating Cash Flow-5.72M
Free Cash Flow-5.72M
Free Cash Flow per Share-0.82
Dividends & Yields
Edesa Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.58
52-Week Price Change-54.93%
50-Day Moving Average2.29
200-Day Moving Average2.82
Relative Strength Index (RSI)37.03
Average Volume (3m)12.50K
Important Dates
Edesa Biotech upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend Date―
Financial Position
Edesa Biotech as a current ratio of 0.91, with Debt / Equity ratio of 0.00%
Current Ratio0.91
Quick Ratio0.91
Debt to Market Cap0.00
Net Debt to EBITDA0.17
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Edesa Biotech has paid 800.00 in taxes.
Income Tax800.00
Effective Tax Rate>-0.01
Enterprise Valuation
Edesa Biotech EV to EBITDA ratio is -2.21, with an EV/FCF ratio of -2.70.
EV to Sales0.00
EV to EBITDA-2.21
EV to Free Cash Flow-2.70
EV to Operating Cash Flow-2.70
Balance Sheet
Edesa Biotech has $13.90M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$13.90M billion.
Cash & Marketable Securities$13.90M
Total Debt$0.00
Net Cash-$13.90M
Net Cash Per Share-$1.98
Tangible Book Value Per Share-$0.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Edesa Biotech is $21.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$21.00
Price Target Upside944.78% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast-126.54%